Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: Differential involvement of the basolateral amygdala and medial prefrontal cortex

Neuroscience

Volumn 173, Issue , 2011, Pages 82-92

  Bijlsma, E Y ^a   van Leeuwen, M L F ^a   Westphal, K G C ^a   Olivier, B ^a,b   Groenink, L ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CRH; Fear potentiated startle; Light enhanced startle; Prepulse inhibition; Repeated administration; Startle

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; ASSOCIATION; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DISEASE EXACERBATION; FEAR; LONG TERM EXPOSURE; MALE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING; SIGNAL TRANSDUCTION; STARTLE REFLEX;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; CORTICOTROPIN-RELEASING HORMONE; FEAR; INJECTIONS, INTRAVENTRICULAR; MALE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 78650679210     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.11.026     Document Type: Article

References (70)

1. Austin M.C., Janosky J.E., Murphy H.A. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 2003, 8:324-332.
2. Bakshi V.P., Geyer M.A. Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience 1999, 92:113-121.
3. Bale T.L., Giordano F.J., Hickey R.P., Huang Y., Nath A.K., Peterson K.L., Vale W.W., Lee K.F. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci U S A 2002, 99:7734-7739.
4. Banki C.M., Bissette G., Arato M., O'Connor L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 1987, 144:873-877.
5. Bittencourt J.C., Sawchenko P.E. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J Neurosci 2000, 20:1142-1156.
6. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
7. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 1992, 49:206-215.
8. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., Nemeroff C.B., Charney D.S. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997, 154:624-629.
9. Bubser M., Koch M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology (Berl) 1994, 113:487-492.
10. Campeau S., Davis M. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 1995, 15:2301-2311.
11. Catalan R., Gallart J.M., Castellanos J.M., Galard R. Plasma corticotropin-releasing factor in depressive disorders. Biol Psychiatry 1998, 44:15-20.
12. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995, 15:6340-6350.
13. Contarino A., Gold L.H. Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior. Neuropeptides 2002, 36:103-116.
14. Conti L., Murry J., Ruiz M., Printz M. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology 2002, 161:296-303.
15. Conti L.H., Berridge C.W., Tayler J.E. Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor. Pharmacol Biochem Behav 2006, 85:261-272.
16. Cook E.W., Hawk L.W., Davis T.L., Stevenson V.E. Affective individual differences and startle reflex modulation. J Abnorm Psychol 1991, 100:5-13.
17. Corr P.J., Kumari V., Wilson G.D., Checkley S., Gray J.A. Harm avoidance and affective modulation of the startle reflex: a replication. Personal Individ Dif 1997, 22:591-593.
18. Daniels W.M., Richter L., Stein D.J. The effects of repeated intra-amygdala CRF injections on rat behavior and HPA axis function after stress. Metab Brain Dis 2004, 19:15-23.
19. Davidson R.J., Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999, 3:11-21.
20. Davis M., Falls W.A., Campeau S., Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 1993, 58:175-198.
21. Decker M.W., Curzon P., Brioni J.D. Influence of separate and combined septal and amygdala lesions on memory, acoustic startle, anxiety, and locomotor activity in rats. Neurobiol Learn Mem 1995, 64:156-168.
22. de Jongh R., Groenink L., van der Gugten J., Olivier B. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone. Biol Psychiatry 2003, 54:1041-1048.
23. De Souza E.B. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J Neurosci 1987, 7:88-100.
24. Dichter G.S., Tomarken A.J., Shelton R.C., Sutton S.K. Early- and late-onset startle modulation in unipolar depression. Psychophysiology 2004, 41:433-440.
25. Dirks A., Groenink L., Schipholt M.I., van der Gugten J., Hijzen T.H., Geyer M.A., Olivier B. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biol Psychiatry 2002, 51:583-590.
26. Dunn A.J., Berridge C.W. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 1987, 27:685-691.
27. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 1996, 75:535-542.
28. Fendt M., Koch M., Schnitzler H.U. Sensorimotor gating deficit after lesions of the superior colliculus. Neuroreport 1994, 5:1725-1728.
29. Fendt M., Koch M., Schnitzler H.U. Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat. Eur J Neurosci 1997, 9:299-305.
30. Forbes E.E., Miller A., Cohn J.F., Fox N.A., Kovacs M. Affect-modulated startle in adults with childhood-onset depression: relations to bipolar course and number of lifetime depressive episodes. Psychiatry Res 2005, 134:11-25.
31. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 1992, 32:939-943.
32. Groenink L., Bijlsma E.Y., Olivier B. Fear-potentiated startle and light-enhanced startle models in drug discovery. Curr Protoc Pharmacol 2008, 5(48):1-15.
33. Groenink L., Dirks A., Verdouw P.M., de Graaff M., Peeters B.W., Millan M.J., Olivier B. CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF. Biol Psychiatry 2008, 63:360-368.
34. Herringa R.J., Roseboom P.H., Kalin N.H. Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects. Neuropsychopharmacology 2006, 31:1822-1831.
35. Hubbard D.T., Nakashima B.R., Lee I., Takahashi L.K. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience 2007, 150:818-828.
36. Jaferi A., Bhatnagar S. Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxiety-related behavior regardless of prior stress experience. Brain Res 2007, 1186:212-223.
37. Jochman K.A., Newman S.M., Kalin N.H., Bakshi V.P. Corticotropin-releasing factor-1 receptors in the basolateral amygdala mediate stress-induced anorexia. Behav Neurosci 2005, 119:1448-1458.
38. Kaviani H., Gray J.A., Checkley S.A., Raven P.W., Wilson G.D., Kumari V. Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. J Affect Disord 2004, 83:21-31.
39. Koch M. The neurobiology of startle. Prog Neurobiol 1999, 59:107-128.
40. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999, 848:141-152.
41. Lang P.J., Bradley M.M., Cuthbert B.N. Emotion, attention, and the startle reflex. Psychol Rev 1990, 97:377-395.
42. Lavicky J., Dunn A.J. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 1993, 60:602-612.
43. Lee R., Geracioti T.D., Kasckow J.W., Coccaro E.F. Childhood trauma and personality disorder: positive correlation with adult CSF corticotropin-releasing factor concentrations. Am J Psychiatry 2005, 162:995-997.
44. Liang K.C., Lee E.H. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology (Berl) 1988, 96:232-236.
45. Lowry C.A., Moore F.L. Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol 2006, 146:19-27.
46. Magalhaes A.C., Holmes K.D., Dale L.B., Comps-Agrar L., Lee D., Yadav P.N., Drysdale L., Poulter M.O., Roth B.L., Pin J.-P., Anisman H., Ferguson S.S.G. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat Neurosci 2010, 13:622-629.
47. Maillot C., Wang L., Million M., Tache Y. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats. Brain Res 2003, 974:70-81.
48. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 2004, 24:1478-1485.
49. Merali Z., Kent P., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., Bedard T., Anisman H. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry 2006, 59:594-602.
50. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988, 45:577-579.
51. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
52. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 2004, 24:3471-3479.
53. Risbrough V.B., Hauger R.L., Roberts A.L., Vale W.W., Geyer M.A. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 2004, 24:6545-6552.
54. Rivier C., Vale W. Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology 1984, 114:914-921.
55. Roozendaal B., Brunson K.L., Holloway B.L., McGaugh J.L., Baram T.Z. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci U S A 2002, 99:13908-13913.
56. Roozendaal B., Schelling G., McGaugh J.L. Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the {beta}-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation. J Neurosci 2008, 28:6642-6651.
57. Sajdyk T.J., Gehlert D.R. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Brain Res 2000, 877:226-234.
58. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 1999, 100:207-215.
59. Sautter F.J., Bissette G., Wiley J., Manguno-Mire G., Schoenbachler B., Myers L., Johnson J.E., Cerbone A., Malaspina D. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry 2003, 54:1382-1388.
60. Shoemaker J.M., Pitcher L., Noh H.R., Swerdlow N.R. Quetiapine produces a prolonged reversal of the sensorimotor gating-disruptive effects of basolateral amygdala lesions in rats. Behav Neurosci 2003, 117:136-143.
61. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994, 51:139-154.
62. Swerdlow N.R., Britton K.T., Koob G.F. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology 1989, 2:285-292.
63. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 2001, 156:194-215.
64. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
65. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000, 428:191-212.
66. Veening J.G., Bocker K.B., Verdouw P.M., Olivier B., De Jongh R., Groenink L. Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms. Neuroscience 2009, 163:1046-1060.
67. Walker D., Yang Y., Ratti E., Corsi M., Trist D., Davis M. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology 2008, 34:1533-1542.
68. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997, 17:9375-9383.
69. Walker D.L., Rattiner L.M., Davis M. Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behav Neurosci 2002, 116:1075-1083.
70. Wan F.J., Swerdlow N.R. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience 1996, 76:715-724.